575 results on '"Riechelmann, Rachel"'
Search Results
2. Impact of the Early Phase of the COVID-19 Pandemic on the Quality of Care for Colorectal and Anal Cancers at Comprehensive Cancer Centers on Two Continents
3. Workup of Newly Diagnosed NENs
4. Differentiating high-grade neuroendocrine neoplasms
5. Effects of Palliative Chemotherapy in Unresectable or Metastatic Colorectal Cancer Patients With Poor Performance Status
6. HPV virus and biomarkers of resistance to chemoradiation in circulating tumor cells from patients with squamous cell carcinoma of the anus
7. SURVEY NEN INQUÉRITO NEN
8. Cure Rates According to Dose-Intensity of Chemoradiation in T2N0 Squamous Cell Carcinoma of the Anal Canal
9. Update in the management of gastroenteropancreatic neuroendocrine tumors.
10. Outcomes of Patients With Metastatic Anal Cancer According to HIV Infection: A Multicenter Study by the Latin American Gastrointestinal Oncology Group (SLAGO)
11. Sample Size Calculation in Oncology Studies
12. Meta-Research in Oncology
13. Interpretation of Results from Tables, Graphs, and Regressions in Cancer Research
14. Identifying Bias in Clinical Cancer Research
15. Ethics in Clinical Cancer Research
16. The Many Different Designs of Phase II Trials in Oncology
17. Resolution of Gastric Cancer-Promoting Inflammation: A Novel Strategy for Anti-cancer Therapy
18. oss of CDX2 and high COX2 (PTGS2) expression in metastatic colorectal cancer
19. Disparities in access to health care system as determinant of survival for patients with pancreatic cancer in the State of São Paulo, Brazil
20. QUIMIOTERAPIA PALIATIVA BENEFICIA PACIENTES COM CANCER AVANÇADO E BAIXO PERFORMANCE?
21. Primary Tumor Location Is a Predictor of Poor Prognosis in Patients with Locally Advanced Esophagogastric Cancer Treated with Perioperative Chemotherapy
22. Fluorouracil Bolus Use in Infusional Regimens Among Oncologists—A Survey by Brazilian Group of Gastrointestinal Tumors
23. Treatment of patients with metastatic colorectal cancer and poor performance status: current evidence and challenges
24. Current approaches to immunotherapy in noncolorectal gastrointestinal malignancies
25. Carcinoid syndrome: update on the pathophysiology and treatment
26. Impact of ypT, ypN, and Adjuvant Therapy on Survival in Gastric Cancer Patients Treated with Perioperative Chemotherapy and Radical Surgery
27. Impact of the COVID-19 Pandemic on Oncology Clinical Research in Latin America (LACOG 0420)
28. Influence of proton pump inhibitors on the pathological response of rectal cancer: a multicentre study
29. Allocation of authorship and patient enrollment among global clinical trials in oncology
30. Angiotensin receptor blockers and severe diarrhea and/or enterocolitis induced by CAPOX in patients with colorectal cancer: A multicentric cohort.
31. Unresectable metastatic colorectal cancer in fit patients – a practical algorithm of treatment sequencing from the Brazilian Group of Gastrointestinal Tumours (GTG)
32. Therapy Sequencing in Patients With Advanced Neuroendocrine Neoplasms
33. Brazilian Society of Surgical Oncology: Guidelines for the management of anal canal cancer
34. International Validation of the EORTC QLQ-ANL27, a Field Study to Test the Anal Cancer-Specific Health-Related Quality-of-Life Questionnaire
35. Metastatic pheochromocytoma and paraganglioma: a retrospective multicentre analysis on prognostic and predictive factors to chemotherapy
36. Germline pathogenic variants in patients with early onset neuroendocrine neoplasms
37. Inpatient palliative chemotherapy is associated with high mortality and aggressive end-of-life care in patients with advanced solid tumors and poor performance status
38. Distinct systemic immune networks define severe vs. mild COVID-19 in hematologic and solid cancer patients
39. Impact of Granulocyte Colony-Stimulating Factor (G-CSF) on the Outcomes of Patients With Metastatic Pancreatic Adenocarcinoma (MPA) During First-Line Treatment With FOLFIRINOX: A Single-Center Retrospective Analysis
40. A systematic review of therapeutic strategies in gastroenteropancreatic grade 3 neuroendocrine tumors
41. HORMONET: a phase II trial of tamoxifen for estrogen/progesterone receptor-positive neuroendocrine tumors
42. Adherence to colonoscopy recommendations for first-degree relatives of young patients diagnosed with colorectal cancer
43. Li–Fraumeni-associated pancreatic neuroendocrine tumour and XAF1 p.Glu134Ter risk modifier variant
44. Supplemental Material - Impact of Granulocyte Colony-Stimulating Factor (G-CSF) on the Outcomes of Patients With Metastatic Pancreatic Adenocarcinoma (MPA) During First-Line Treatment With FOLFIRINOX: A Single-Center Retrospective Analysis
45. Supplemental Material - Current Treatment of Potentially Resectable Pancreatic Ductal Adenocarcinoma: A Medical Oncologist’s Perspective
46. Poorly Differentiated Neuroendocrine Tumors
47. International comparison of the impact of COVID on adherence with supportive care focused Choosing Wisely recommendations (CWR).
48. The Current and Evolving Role of Immunotherapy in Metastatic Colorectal Cancer
49. Evaluation of 18F-FDG PET-CT as a prognostic marker in advanced biliary tract cancer
50. Germline pathogenic variants in patients with early-onset neuroendocrine neoplasms.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.